Decker’s decision to align with the Columbus-based clinic follows her own search for care that prioritizes patient concerns over standard lab metrics. Dr. Jessica Duncan, Chief Medical Officer at Ivim, notes that many women arrive with normal test results while still feeling unwell. According to the practice, the core of their model relies on incorporating patient-reported symptoms—such as mood shifts, fatigue, and brain fog—directly into the clinical planning process.
Since launching its Women’s Hormone Health program in June 2026, Ivim has utilized a proprietary assessment tool, HormoneIQ, to track symptom burden. The company reports that 95% of patients in this program felt improvement within 90 days. While Decker will share her experiences across her social channels and participate in upcoming media events, her agreement stipulates she cannot be prompted to endorse specific clinical outcomes, leaving all treatment decisions to licensed professionals.

Comments (0)
No comments yet. Be the first!